No Access
SPOTLIGHTS
https://doi.org/10.1142/S0219030316000732Cited by:0 (Source: Crossref)
Abstract
Partnership with Bayer Addressing Healthcare Needs.
Exploring the Factors behind Heart Failure Disease in Asia.
Tobacco Harm Reduction and Reduced-Risk Products.
Keywords:
- partnership
- Bayer
- healthcare
- innovation
- cardiovascular diseases (CVD)
- digital health technology
- wearables
- sensor technologies
- entrepreneurs
- challenges
- pharmaceutical companies
- clinical studies
- value
- R&D
- heart failure
- Asia
- ASIAN-HF
- coronary artery disease
- hypertension
- diabetes
- tobacco
- harm
- risk
- PMI
- reduced-risk products (RRPs)
- cigarette smoking
